JULIE ROUBAL: Open Payments
NPI 1114975489 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,550 in 66 payments from 14 companies in 2025. Trend: 2023 $135 · 2024 $489 · 2025 $1,550
Food & beverage: $1,455Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $321 |
| Regeneron Healthcare Solutions, Inc. | 6 | $194 |
| UCB, Inc. | 8 | $188 |
| LEO Pharma Inc. | 8 | $177 |
| Novartis Pharmaceuticals Corporation | 6 | $147 |
| ABBVIE INC. | 4 | $103 |
| Amgen Inc. | 4 | $91 |
| Lilly USA, LLC | 4 | $87 |
| Botanix SB Inc | 3 | $60 |
| GENZYME CORPORATION | 2 | $48 |
Products named: TREMFYA, Bimzelx, DUPIXENT, COSENTYX, ADBRY, SKYRIZI, TALTZ, ANZUPGO.
Industry payments across NE — which companies pay providers there.
